The Role of Capabilities in Linkage Formation and Actor Positioning within Innovation Ecosystems: A Case Study of Iran's Vaccine Industry

Document Type : Research Paper

Authors

1 Department of Technology Management and Entrepreneurship, Allameh Tabataba'i University, Tehran, Iran

2 Baqiyatallah University of Medical Sciences, Tehran, Iran

Abstract

This study explores the role of capabilities in actor positioning and linkage formation within innovation ecosystems, by investigation the Iran’s vaccine industry during the COVID-19 pandemic as a case. It examines how capabilities shape actors’ strategic positioning, the quantity and quality of their linkages, and their participation in key ecosystem activities. The research adopts a case-study approach, incorporating qualitative thematic analysis and quantitative content analysis of data from 20 in-depth interviews with experts, researcher own observations as vaccine expert, and national and international reports. The findings reveal key capabilities, such as research and development (R&D), supply chain management, and financial resources, significantly impact actors’ roles and linkage dynamics in the innovation ecosystem. Actors with advanced strategic and operational capabilities often assume pivotal roles, establishing high-quality linkages and contributing effectively to joint value creation. The study underscores the need for redesigning the vaccine innovation ecosystem by fostering public-private collaboration, incentivizing private sector engagement, and facilitating access to advanced technologies. It highlights the government’s role as an orchestrator in strengthening regulatory frameworks, enabling actor interactions, and supporting operational, strategic, and dynamic capabilities through targeted funding and shared infrastructure. Additionally, establishing knowledge-sharing networks and international collaboration platforms is recommended to accelerate innovation and enhance ecosystem cohesion.
Theoretically, the research enriches strategic management literature by emphasizing the alignment of actor capabilities with innovation ecosystem goals and interdependencies. It provides actionable insights for improving innovation ecosystems, particularly in strategic industries such as vaccine development, and offers a foundation for future research on complex and evolving ecosystems. This study ultimately contributes to understanding how capabilities influence innovation ecosystem structure interactions and success.

Keywords

References

منابع

ملک اخلاق، اسماعیل و دوستار، محمد و یزدانی، مهدی،1393،بررسی تأثیر قابلیتهای محوری و استراتژی رقابتی بر عملکردمورد مطالعه: شرکتهای ساختمانی کوچک و متوسط استان تهران،دومین همایش ملی کارآفرینی و رقابت پذیری،ساری،https://civilica.com/doc/280491
 
References
 
Adner, R. (2017). Ecosystem as structure: An actionable construct for strategy. Journal of Management, 43(1), 39–58. https://doi.org/10.1177/0149206316678451
Adner, R., & Kapoor, R. (2010). Value creation in innovation ecosystems: How the structure of technological interdependence affects firm performance in new technology generations. Strategic Management Journal, 31(3), 306–333. https://doi.org/10.1002/smj.821
Barney, J. B. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120. https://doi.org/10.1177/014920639101700108
Bâton Global. (n.d.). Dynamic capabilities: The source of competitive advantage. Retrieved January 12, 2025, from https://www.batonglobal.com/post/dynamic-capabilities-the-source-of-competitive-advantage
Contreras, J. L., & Shadlen, K. C. (2024). Contrasting academic approaches to COVID-19 vaccine production and distribution: What can the Oxford and Texas experiences teach us about pandemic response? Health Affairs Scholar, 2.
Deloitte. (2021). The COVID-19 vaccine supply chain: Innovating for the future. Deloitte. https://www2.deloitte.com
Felin, T., Foss, N. J., & Ployhart, R. E. (2015). The microfoundations movement in strategy and organization theory. Academy of Management Annals, 9(1), 575-632. https://doi.org/10.1080/19416520.2015.1007651
Fukuyama, F. (1995). Trust: The social virtues and the creation of prosperity. Free Press.
Ghanei, M., A. Mohabattalab, K. Fartash, N. Kolahchi, A. Khakdaman, H. Kaghazian, and A. Bagheri. 2023. "Exploring the Experience of Developing COVID-19 Vaccines in Iran." Clinical and Experimental Vaccine Research 12 (1): 1.
Goldstein, J. R., Gorrie, C., & Holbrook, K. (2021). Coordinating the COVID-19 vaccine supply chain: Lessons from logistics. Harvard Business Review. https://hbr.org/2021/03/coordinating-the-covid-19-vaccine-supply-chain
Granstrand, O., & Holgersson, M. (2020). Innovation ecosystems: A conceptual review and a new definition. Technovation, 90–91, 102098. https://doi.org/10.1016/j.technovation.2019.102098
Grant, R. M. (2018). Contemporary strategy analysis (10th ed.). Wiley.
Iansiti, M., & Levien, R. (2004). The keystone advantage: What the new dynamics of business ecosystems mean for strategy, innovation, and sustainability. Harvard Business School Press.
Ilin, I., A. Levina, and K. Frolov. 2022. "Innovative Ecosystem Model of Vaccine Lifecycle Management." Journal of Open Innovation: Technology, Market, and Complexity 8 (1): 5. https://doi.org/10.3390/joitmc8010005.
McKinsey & Company. (2021). Understanding the vaccine distribution challenge. McKinsey & Company. https://www.mckinsey.com
Moeenian, M., S. Ghazinoory, and P. Yaghmaie. 2024. "Analyzing the Performance of a Health Innovation Ecosystem in the COVID-19 Crisis: Complexity and Chaos Theory Perspective." Health Research Policy and Systems 22 (1): 59.
Moore, J. F. (1993). Predators and prey: A new ecology of competition. Harvard Business Review, 71(3), 75–86.
Nalebuff, B., & Brandenburger, A. (1996). Co-opetition. HarperCollins.
Nelson, R. R., & Winter, S. G. (1982). An evolutionary theory of economic change. Belknap Press of Harvard University Press. https://doi.org/10.4159/9780674045174
O'Reilly III, C. A., & Tushman, M. L. (2013). Organizational ambidexterity: Past, present, and future. Academy of management Perspectives, 27(4), 324-338.Grant, R. M. (1991). The resource-based theory of competitive advantage: Implications for strategy formulation. California Management Review, 33(3), 114–135. https://doi.org/10.2307/41166664
Peltoniemi, M. (2006). Business ecosystem as the new approach to complex adaptive business environments. Emergence: Complexity and Organization, 8(1), 10–19.
Penrose, E. (1959). The theory of the growth of the firm. Oxford University Press.
Plotkin, S. A., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2021). The complexity and cost of vaccine manufacturing—An overview. Vaccine, 39(15), 2190–2201. https://doi.org/10.1016/j.vaccine.2021.02.072
Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79–91.
Rashid, S., and V. Ratten. 2021. "Entrepreneurial Ecosystems during COVID-19: The Survival of Small Businesses Using Dynamic Capabilities." World Journal of Entrepreneurship, Management and Sustainable Development 17 (3): 457–. https://doi.org/10.1108/WJEMSD-09-2020-0110.
Ritala, P. (2013). Co-creation and co-opetition in strategic partnerships: The role of interfirm trust. Industrial Marketing Management, 42(4), 622–631. https://doi.org/10.1016/j.indmarman.2013.05.008
Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management/RB Lamb.
Tahouri, H., H. Tabatabaian, M. R. Taqwa, and S. M. T. Taghavifard. 2018. "An Analysis of the Biotechnology Innovation Ecosystem of Human Vaccines in Iran." (In Persian) Journal of Science and Technology Policy 9 (3): 369–384.
Teece, D. J. (2007). Explicating dynamic capabilities: The nature and microfoundations of sustainable enterprise performance. Strategic Management Journal, 28(13), 1319–1350. https://doi.org/10.1002/smj.640
Teece, D. J. (2017). Dynamic capabilities and entrepreneurial management in large organizations: Toward a theory of the (entrepreneurial) firm. European Economic Review, 86, 202–216. https://doi.org/10.1016/j.euroecorev.2015.11.006
Teece, D. J. (2018). Business models and dynamic capabilities. Long Range Planning, 51(1), 40–49. https://doi.org/10.1016/j.lrp.2017.06.007
Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)1097-0266(199708)18:7<509: AID-SMJ882>3.0.CO;2-Z
Wernerfelt, B. (1984). A resource-based view of the firm. Strategic Management Journal, 5(2), 171–180. https://doi.org/10.1002/smj.4250050207
World Health Organization (WHO). (2021). WHO guidance on COVID-19 vaccine supply chain and logistics. World Health Organization. https://www.who.int/publications-detail/who-guidance-on-covid-19-vaccine-supply-chain-and-logistics
Yin, R. K. (2018). Case study research and applications.
Zhang, Y., Li, H., Xu, X., & Antwi, H. A. (2023). On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation. Frontiers in Public Health, 11.
Innovation Economic Ecosystem Studies
Volume 5, Issue 1
January 2025
Pages 127-155

Files

Share

How to cite

Statistics